Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Vincent Bours

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Physiology

Procedures

Gene Therapy

Disorders

Living Beings

Mice

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
64
Merville, Marie-Paule
24
Chariot, Alain
22
Gielen, Jacques
21
Piette, Jacques
17
Fillet, Georges
14
Bentires-Alj, Mohamed
14
Siebenlist, Ulrich
12
Robe, Pierre
12
Princen, Fred
11
Bonizzi, G
11
Benoit, Valérie
10
Lechanteur, Chantal
9
Deregowski, Valérie
9
Mutesa, Léon
8
Dejardin, Emmanuel

Sign-in to see all Coauthors

Publications

TOP 3
Théâtre Emilie; Bours Vincent; Oury Cécile
A P2X ion channel-triggered NF-kappaB pathway enhances TNF-alpha-induced IL-8 expression in airway epithelial cells.
Mutesa Léon; Bours Vincent
Diagnostic challenges of cystic fibrosis in patients of African origin.
Lecut Christelle; Frederix Kim; Johnson Daniel M; Deroanne Christophe; Thiry Marc; Faccinetto Céline; Marée Raphaël; Evans Richard J; Volders Paul G A; Bours Vincent; Oury Cécile
P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Vincent Bours (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Théâtre Emilie; Bours Vincent; Oury Cécile
A P2X ion channel-triggered NF-kappaB pathway enhances TNF-alpha-induced IL-8 expression in airway epithelial cells.
American journal of respiratory cell and molecular biology 2009;41(6):705-13.
2009: Mutesa Léon; Bours Vincent
Diagnostic challenges of cystic fibrosis in patients of African origin.
Journal of tropical pediatrics 2009;55(5):281-6.
2009: Lecut Christelle; Frederix Kim; Johnson Daniel M; Deroanne Christophe; Thiry Marc; Faccinetto Céline; Marée Raphaël; Evans Richard J; Volders Paul G A; Bours Vincent; Oury Cécile
P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(4):2801-9.
2009: Boemer François; Bours Vincent; Schoos Roland; Hubert Philippe; Rozet Eric
Analytical validation based on total error measurement and cut-off interpretation of a neonatal screening TSH-immunoassay.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(23):2412-7.
2009: Mutesa Léon; Azad Abul Kalam; Verhaeghe Catherine; Segers Karin; Vanbellinghen Jean-François; Ngendahayo Louis; Rusingiza Emmanuel Kamanzi; Mutwa Philippe Rutwaza; Rulisa Stephen; Koulischer Lucien; Cassiman Jean-Jacques; Cuppens Harry; Bours Vincent
Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants.
Chest 2009;135(5):1233-42.
2009: Robe Pierre A; Martin Didier H; Nguyen-Khac Minh T; Artesi Maria; Deprez Manuel; Albert Adelin; Vanbelle Sophie; Califice Stephane; Bredel Markus; Bours Vincent
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults.
BMC cancer 2009;9():372.
2009: Mutesa L; Vanbellinghen J F; Hellin A C; Segers K; Jamar M; Pierquin G; Bours V
Deletion of Xpter encompassing the SHOX gene and PAR1 region in familial patients with Leri-Weill Dyschondrosteosis syndrome.
Genetic counseling (Geneva, Switzerland) 2009;20(1):9-17.
2008: Boemer François; Ketelslegers Olivier; Minon Jean-Marc; Bours Vincent; Schoos Roland
Newborn screening for sickle cell disease using tandem mass spectrometry.
Clinical chemistry 2008;54(12):2036-41.
2008: Mutesa Léon; Pierquin Geneviève; Segers Karin; Vanbellinghen Jean François; Gahimbare Laetitia; Bours Vincent
Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis.
Journal of tropical pediatrics 2008;54(5):350-2.
2008: Mutesa Léon; Pierquin Geneviève; Janin Nicolas; Segers Karin; Thomée Caroline; Provenzi Massimo; Bours Vincent
Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors.
Cancer genetics and cytogenetics 2008;182(1):40-2.
2008: Reenaers Catherine; Franchimont Nathalie; Oury Cecile; Belaiche Jacques; Malaise Michel; Bours Vincent; Theatre Emilie; Delvenne Philippe; Louis Edouard
Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease.
Scandinavian journal of gastroenterology 2008;43(11):1334-45.
2007: Dideberg Vinciane; Kristjansdottir Gudlaug; Milani Lili; Libioulle Cécile; Sigurdsson Snaevar; Louis Edouard; Wiman Ann-Christin; Vermeire Séverine; Rutgeerts Paul; Belaiche Jacques; Franchimont Denis; Van Gossum André; Bours Vincent; Syvänen Ann-Christine
An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
Human molecular genetics 2007;16(24):3008-16.
2007: Mutesa Léon; Muganga Narcisse; Lissens Willy; Boemer François; Schoos Roland; Pierquin Geneviève; Bours Vincent
Molecular analysis in two siblings African patients with severe form of Hunter Syndrome: identification of a novel (p.Y54X) nonsense mutation.
Journal of tropical pediatrics 2007;53(6):434-7.
2007: Naves Luciana A; Daly Adrian F; Vanbellinghen Jean-François; Casulari Luiz A; Spilioti Cristina; Magalhães Albino V; Azevedo Monalisa F; Giacomini Leonardo A; Nascimento Paula P; Nunes Rousielysson O; Rosa Joao W C; Jaffrain-Rea Marie-Lise; Bours Vincent; Beckers Albert
Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene.
European journal of endocrinology / European Federation of Endocrine Societies 2007;157(4):383-91.
2007: Lambert Frédéric; Heimann Pierre; Herens Christian; Chariot Alain; Bours Vincent
A case of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia with a rare FIP1L1 breakpoint.
The Journal of molecular diagnostics : JMD 2007;9(3):414-9.
2007: Verhaeghe Catherine; Delbecque Katty; de Leval Laurence; Oury Cecile; Bours Vincent
Early inflammation in the airways of a cystic fibrosis foetus.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2007;6(4):304-8.
2007: Verhaeghe Catherine; Remouchamps Caroline; Hennuy Benoît; Vanderplasschen Alain; Chariot Alain; Tabruyn Sebastien P; Oury Cecile; Bours Vincent
Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
Biochemical pharmacology 2007;73(12):1982-94.
2007: Verhaeghe Catherine; Tabruyn Sebastien P; Oury Cecile; Bours Vincent; Griffioen Arjan W
Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells.
Biochemical and biophysical research communications 2007;356(3):745-9.
2007: Barlier Anne; Vanbellinghen Jean-François; Daly Adrian F; Silvy Monique; Jaffrain-Rea Marie-Lise; Trouillas Jacqueline; Tamagno Gianluca; Cazabat Laure; Bours Vincent; Brue Thierry; Enjalbert Alain; Beckers Albert
Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
The Journal of clinical endocrinology and metabolism 2007;92(5):1952-5.
2007: Meuwis Marie-Alice; Fillet Marianne; Geurts Pierre; de Seny Dominique; Lutteri Laurence; Chapelle Jean-Paul; Bours Vincent; Wehenkel Louis; Belaiche Jacques; Malaise Michel; Louis Edouard; Merville Marie-Paule
Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling.
Biochemical pharmacology 2007;73(9):1422-33.
2007: Mutesa L; Pierquin G; Cwiny-Ay N; Buzizi P; Bours V
[Hutchinson-Gilford progeria syndrome: clinical and molecular analysis in an African patient]
Revue médicale de Liège 2007;62(3):155-8.
2007: Robe Pierre A; Nguyen-Khac Minh-Tuan; Lambert Frederic; Lechanteur Chantal; Jolois Olivier; Ernst-Gengoux Patricia; Rogister Bernard; Bours Vincent
Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas.
International journal of oncology 2007;30(1):283-90.
2007: Mutesa Léon; Boemer François; Ngendahayo Louis; Rulisa Stephen; Rusingiza Emmanuel K; Cwinya-Ay Neniling; Mazina Déogratias; Kariyo Pierre C; Bours Vincent; Schoos Roland
Neonatal screening for sickle cell disease in Central Africa: a study of 1825 newborns with a new enzyme-linked immunosorbent assay test.
Journal of medical screening 2007;14(3):113-6.
2007: Mutesa L; Hellin A C; Jamar M; Pierquin G; Bours V; Verloes A
Precocious puberty associated with partial trisomy 18q and monosomy 11q.
Genetic counseling (Geneva, Switzerland) 2007;18(2):201-7.
2006: Dideberg Vinciane; Théâtre Emilie; Farnir Frédéric; Vermeire Séverine; Rutgeerts Paul; De Vos Martine; Belaiche Jacques; Franchimont Denis; Van Gossum André; Louis Edouard; Bours Vincent
The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease.
Pharmacogenetics and genomics 2006;16(10):727-34.
2006: Olivier Sabine; Robe Pierre; Bours Vincent
Can NF-kappaB be a target for novel and efficient anti-cancer agents?
Biochemical pharmacology 2006;72(9):1054-68.
2006: Benoit V; de Moraes E; Dar N A; Taranchon E; Bours V; Hautefeuille A; Tanière P; Chariot A; Scoazec J-Y; de Moura Gallo C V; Merville M-P; Hainaut P
Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB.
Oncogene 2006;25(42):5708-18.
2006: Relic Biserka; Benoit Valérie; Franchimont Nathalie; Kaiser Marie-Joelle; Hauzeur Jean-Philippe; Gillet Philippe; Merville Marie-Paule; Bours Vincent; Malaise Michel G
Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis.
The Journal of biological chemistry 2006;281(32):22597-604.
2006: Close Pierre; Hawkes Nicola; Cornez Isabelle; Creppe Catherine; Lambert Charles A; Rogister Bernard; Siebenlist Ulrich; Merville Marie-Paule; Slaugenhaupt Susan A; Bours Vincent; Svejstrup Jesper Q; Chariot Alain
Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia.
Molecular cell 2006;22(4):521-31.
2006: Dideberg Vinciane; Louis Edouard; Farnir Frédéric; Bertoli Sabrina; Vermeire Séverine; Rutgeerts Paul; De Vos Martine; Van Gossum André; Belaiche Jacques; Bours Vincent
Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study.
Pharmacogenetics and genomics 2006;16(5):369-73.
2006: Olivier Sabine; Close Pierre; Castermans Emilie; de Leval Laurence; Tabruyn Sebastien; Chariot Alain; Malaise Michel; Merville Marie-Paule; Bours Vincent; Franchimont Nathalie
Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
Molecular pharmacology 2006;69(5):1615-23.
2006: Herens C; Ketelslegers O; Tassin F; Hansen S; Bours V
Inositide-specific phospholipase c beta1 gene deletion is a rare event in myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(3):521-2; author reply 522-3.
2006: Bonif Marianne; Meuwis Marie-Alice; Close Pierre; Benoit Valérie; Heyninck Karen; Chapelle Jean-Paul; Bours Vincent; Merville Marie-Paule; Piette Jacques; Beyaert Rudi; Chariot Alain
TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.
The Biochemical journal 2006;394(Pt 3):593-603.
2006: Boemer François; Vanbellinghen Jean-François; Bours Vincent; Schoos Roland
Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns.
Journal of medical screening 2006;13(3):132-6.
2006: Robe Pierre A; Martin Didier; Albert Adelin; Deprez Manuel; Chariot Alain; Bours Vincent
A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668].
BMC cancer 2006;6():29.
2005: Dideberg V; Bours V
[Integration of pharmacogenetics in the medical practice]
Revue médicale de Liège 2005;60(12):918-22.
2005: de Seny Dominique; Fillet Marianne; Meuwis Marie-Alice; Geurts Pierre; Lutteri Laurence; Ribbens Clio; Bours Vincent; Wehenkel Louis; Piette Jacques; Malaise Michel; Merville Marie-Paule
Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
Arthritis and rheumatism 2005;52(12):3801-12.
2005: Fournier Mickaël; Lacrosse Stéphanie; Jamar Mauricette; Bours Vincent; Herens Christian
Deletions of the 3'BCR and 5'ABL regions in patients with Philadelphia-positive chronic myeloid leukemia: a one-step process occurring in about 10% of the cases without any evidence of genetic instability in the target cells.
Cancer genetics and cytogenetics 2005;160(2):184-7.
2005: Olivier Sabine; Fillet Marianne; Malaise Michel; Piette Jacques; Bours Vincent; Merville Marie-Paule; Franchimont Nathalie
Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene.
Biochemical pharmacology 2005;69(6):891-901.
2005: Lechanteur Chantal; Jacobs Nathalie; Greimers Roland; Benoît Valérie; Deregowski Valérie; Chariot Alain; Merville Marie-Paule; Bours Vincent
Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis.
Oncogene 2005;24(10):1788-93.
2005: Viatour Patrick; Merville Marie-Paule; Bours Vincent; Chariot Alain
Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.
Trends in biochemical sciences 2005;30(1):43-52.
2005: Franchimont Nathalie; Lambert Cécile; Huynen Pascale; Ribbens Clio; Relic Biserka; Chariot Alain; Bours Vincent; Piette Jacques; Merville Marie-Paule; Malaise Michel
Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
Arthritis and rheumatism 2005;52(1):84-93.
2005: Robe Pierre A; Nguyen-Khac Minh; Jolois Olivier; Rogister Bernard; Merville Marie-Paule; Bours Vincent
Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells.
BMC cancer 2005;5():32.
2004: Viatour Patrick; Merville Marie-Paule; Bours Vincent; Chariot Alain
Protein phosphorylation as a key mechanism for the regulation of BCL-3 activity.
Cell cycle (Georgetown, Tex.) 2004;3(12):1498-501.
2004: Viatour Patrick; Dejardin Emmanuel; Warnier Michael; Lair Florence; Claudio Estefania; Bureau Fabrice; Marine Jean-Christophe; Merville Marie-Paule; Maurer Ulrich; Green Douglas; Piette Jacques; Siebenlist Ulrich; Bours Vincent; Chariot Alain
GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity.
Molecular cell 2004;16(1):35-45.
2004: Robe Pierre A; Bentires-Alj Mohamed; Bonif Marianne; Rogister Bernard; Deprez Manuel; Haddada Heddi; Khac Minh-Tuan Nguyen; Jolois Olivier; Erkmen Kadir; Merville Marie-Paule; Black Peter M; Bours Vincent
In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5595-603.
2004: Robe Pierre A; Jolois Olivier; N'Guyen Minh; Princen Frederic; Malgrange Brigitte; Merville Marie-Paule; Bours Vincent
Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication.
International journal of oncology 2004;25(1):187-92.
2004: Relic Biserka; Benoit Valérie; Franchimont Nathalie; Ribbens Clio; Kaiser Marie-Joelle; Gillet Philippe; Merville Marie-Paule; Bours Vincent; Malaise Michel G
15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts.
The Journal of biological chemistry 2004;279(21):22399-403.
2004: Benoit Valérie; Chariot Alain; Delacroix Laurence; Deregowski Valérie; Jacobs Nathalie; Merville Marie-Paule; Bours Vincent
Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expression.
Cancer research 2004;64(8):2684-91.
2004: Benoit Valérie; Relic Biserka; Leval Xd Xavier de; Chariot Alain; Merville Marie-Paule; Bours Vincent
Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2.
Oncogene 2004;23(8):1631-5.
2004: Van Lint C; Quivy V; Demonté D; Chariot A; Vanhulle C; de Walque St; Gaudray G; Veithen E; Bours V; Piette J; Burny Ar
Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.
Bulletin et mémoires de l'Académie royale de médecine de Belgique 2004;159(Pt 2):176-89.
2003: Baron Frédéric; Schaaf-Lafontaine Nicole; Humblet-Baron Stéphanie; Meuris Nathalie; Castermans Emilie; Baudoux Etienne; Frère Pascale; Bours Vincent; Fillet Georges; Beguin Yves
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Transplantation 2003;76(12):1705-13.
2003: Herens Christian; Baron Frédéric; Croisiau Christiane; Tassin Francoise; Bours Vincent
Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases.
Cancer genetics and cytogenetics 2003;147(1):78-80.
2003: Viatour Patrick; Legrand-Poels Sylvie; van Lint Carine; Warnier Michael; Merville Marie-Paule; Gielen Jacques; Piette Jacques; Bours Vincent; Chariot Alain
Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.
The Journal of biological chemistry 2003;278(47):46541-8.
2003: Herens Christian; Radermecker Marc; Servais Anne; Quatresooz Pascale; Jardon-Jeghers Claire; Bours Vincent; de Leval Laurence
Deletion (6)(p22p25) is a recurrent anomaly of thymoma: report of a second case and review of the literature.
Cancer genetics and cytogenetics 2003;146(1):66-9.
2003: Adam Emmanuelle; Quivy Vincent; Bex Françoise; Chariot Alain; Collette Yves; Vanhulle Caroline; Schoonbroodt Sonia; Goffin Véronique; Nguyên Thi Liên-Anh; Gloire Geoffrey; Carrard Géraldine; Friguet Bertrand; De Launoit Yvan; Burny Arsène; Bours Vincent; Piette Jacques; Van Lint Carine
Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
Molecular and cellular biology 2003;23(17):6200-9.
2003: Tabruyn Sebastien P; Sorlet Catherine M; Rentier-Delrue Francoise; Bours Vincent; Weiner Richard I; Martial Joseph A; Struman Ingrid
The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB.
Molecular endocrinology (Baltimore, Md.) 2003;17(9):1815-23.
2003: Viatour P; Bentires-Alj M; Chariot A; Deregowski V; de Leval L; Merville M-P; Bours V
NF- kappa B2/p100 induces Bcl-2 expression.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(7):1349-56.
2003: Fillet Marianne; Bentires-Alj Mohamed; Deregowski Valerie; Greimers Roland; Gielen Jacques; Piette Jacques; Bours Vincent; Merville Marie-Paule
Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity.
Biochemical pharmacology 2003;65(10):1633-42.
2003: Chariot Alain; Meuwis Marie-Alice; Bonif Marianne; Leonardi Antonio; Merville Marie-Paule; Gielen Jacques; Piette Jacques; Siebenlist Ulrich; Bours Vincent
NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets.
Current medicinal chemistry 2003;10(7):593-602.
2003: Frédérich Michel; Bentires-Alj Mohamed; Tits Monique; Angenot Luc; Greimers Roland; Gielen Jacques; Bours Vincent; Merville Marie-Paule
Isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis, induces cell cycle arrest and apoptosis in human colon cancer cells.
The Journal of pharmacology and experimental therapeutics 2003;304(3):1103-10.
2003: Bentires-Alj Mohamed; Barbu Veronique; Fillet Marianne; Chariot Alain; Relic Biserka; Jacobs Nathalie; Gielen Jacques; Merville Marie-Paule; Bours Vincent
NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells.
Oncogene 2003;22(1):90-7.
2003: Jamar M; Lemarchal C; Lemaire V; Koulischer L; Bours V
A low rate of trisomy 21 in twin-pregnancies: a cytogenetics retrospective study of 278 cases.
Genetic counseling (Geneva, Switzerland) 2003;14(4):395-400.
2002: Relic Biserka; Bentires-Alj Mohamed; Ribbens Clio; Franchimont Nathalie; Guerne Pierre-André; Benoît Valerie; Merville Marie-Paule; Bours Vincent; Malaise Michel G
TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB.
Laboratory investigation; a journal of technical methods and pathology 2002;82(12):1661-72.
2002: Quivy Vincent; Adam Emmanuelle; Collette Yves; Demonte Dominique; Chariot Alain; Vanhulle Caroline; Berkhout Ben; Castellano Rémy; de Launoit Yvan; Burny Arsène; Piette Jacques; Bours Vincent; Van Lint Carine
Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
Journal of virology 2002;76(21):11091-103.
2002: Deregowski Valérie; Delhalle Sylvie; Benoit Valérie; Bours Vincent; Merville Marie-Paule
Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells.
Biochemical pharmacology 2002;64(5-6):873-81.
2002: Polus M; Bours V; Jerusalem G; Sautois B; Fillet G
[How I treat...advanced cancer of the pancreas with a novel approach directed against new targets]
Revue médicale de Liège 2002;57(7):428-32.
2002: Delhalle Sylvie; Deregowski Valérie; Benoit Valérie; Merville Marie-Paule; Bours Vincent
NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis.
Oncogene 2002;21(24):3917-24.
2002: Bureau Fabrice; Vanderplasschen Alain; Jaspar Fabrice; Minner Frédéric; Pastoret Paul-Pierre; Merville Marie-Paule; Bours Vincent; Lekeux Pierre
Constitutive nuclear factor-kappaB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins.
Blood 2002;99(10):3683-91.
2002: Baron Frédéric; Turhan Ali G; Giron-Michel Julien; Azzarone Bruno; Bentires-Alj Mohamed; Bours Vincent; Bourhis Jean Henri; Chouaib Salem; Caignard Anne
Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression.
Blood 2002;99(6):2107-13.
2001: Fiévez L; Kirschvink N; Dogné S; Jaspar F; Merville M P; Bours V; Lekeux P; Bureau F
Impaired accumulation of granulocytes in the lung during ozone adaptation.
Free radical biology & medicine 2001;31(5):633-41.
2001: Bentires-Alj M; Dejardin E; Viatour P; Van Lint C; Froesch B; Reed J C; Merville M P; Bours V
Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.
Oncogene 2001;20(22):2805-13.
2001: Verlaet M; Deregowski V; Denis G; Humblet C; Stalmans M T; Bours V; Castronovo V; Boniver J; Defresne M P
Genetic imbalances in preleukemic thymuses.
Biochemical and biophysical research communications 2001;283(1):12-8.
2001: Princen F; Robe P; Gros D; Jarry-Guichard T; Gielen J; Merville M P; Bours V
Rat gap junction connexin-30 inhibits proliferation of glioma cell lines.
Carcinogenesis 2001;22(3):507-13.
2001: Mami-Chouaib F; Ameyar M; Dorothée G; Bentires-Alj M; Dziembowska M; Delhalle S; Gay F; Stancou R; Bours V; Chouaib S
Effect of nuclear factor kappaB inhibition on tumor cell sensitivity to natural killer-mediated cytolytic function.
European journal of immunology 2001;31(2):433-9.
2000: Hellin A C; Bentires-Alj M; Verlaet M; Benoit V; Gielen J; Bours V; Merville M P
Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis.
The Journal of pharmacology and experimental therapeutics 2000;295(3):870-8.
2000: Bours V; Bonizzi G; Bentires-Alj M; Bureau F; Piette J; Lekeux P; Merville M
NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment.
Toxicology 2000;153(1-3):27-38.
2000: Bureau F; Delhalle S; Bonizzi G; Fiévez L; Dogné S; Kirschvink N; Vanderplasschen A; Merville M P; Bours V; Lekeux P
Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5822-30.
2000: Bours V; Bentires-Alj M; Hellin A C; Viatour P; Robe P; Delhalle S; Benoit V; Merville M P
Nuclear factor-kappa B, cancer, and apoptosis.
Biochemical pharmacology 2000;60(8):1085-9.
2000: Benoit V; Hellin A C; Huygen S; Gielen J; Bours V; Merville M P
Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
Oncogene 2000;19(41):4787-94.
2000: Robe P A; Rogister B; Merville M P; Bours V
Growth regulation of astrocytes and C6 cells by TGFbeta1: correlation with gap junctions.
Neuroreport 2000;11(13):2837-41.
2000: Lechanteur C; Delvenne P; Princen F; Lopez M; Fillet G; Gielen J; Merville M P; Bours V
Combined suicide and cytokine gene therapy for peritoneal carcinomatosis.
Gut 2000;47(3):343-8.
2000: Robe P A; Princen F; Martin D; Malgrange B; Stevenaert A; Moonen G; Gielen J; Merville M; Bours V
Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside.
Biochemical pharmacology 2000;60(2):241-9.
2000: Jerusalem G; Bours V; Fillet G
[Adjuvant treatment of breast cancer: meta-analysis and therapeutic recommendations]
Revue médicale de Liège 2000;55(5):356-9.
2000: Gast P; Bours V; Detroz B; Colette M Y; Booz V
[Guidelines concerning the treatment of rectal cancer]
Revue médicale de Liège 2000;55(5):350-5.
2000: Lechanteur C; Moutschen M; Princen F; Lopez M; Franzen E; Gielen J; Bours V; Merville M P
Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cells.
Cancer gene therapy 2000;7(5):676-82.
2000: Bureau F; Bonizzi G; Kirschvink N; Delhalle S; Desmecht D; Merville M P; Bours V; Lekeux P
Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma.
American journal of respiratory and critical care medicine 2000;161(4 Pt 1):1314-21.
2000: Bentires-Alj M; Hellin A C; Lechanteur C; Princen F; Lopez M; Fillet G; Gielen J; Merville M P; Bours V
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis.
Cancer gene therapy 2000;7(1):20-6.
2000: Locigno R; Antoine N; Bours V; Daukandt M; Heinen E; Castronovo V
TNP-470, a potent angiogenesis inhibitor, amplifies human T lymphocyte activation through an induction of nuclear factor-kappaB, nuclear factor-AT, and activation protein-1 transcription factors.
Laboratory investigation; a journal of technical methods and pathology 2000;80(1):13-21.
2000: Bonizzi G; Piette J; Merville M P; Bours V
Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1.
Biochemical pharmacology 2000;59(1):7-11.
2000: Princen F; Lechanteur C; Lopez M; Gielen J; Bours V; Merville M P
Similar efficiency of DNA-liposome complexes and retrovirus-producing cells for HSV-tk suicide gene therapy of peritoneal carcinomatosis.
Journal of drug targeting 2000;8(2):79-89.
1999: Chariot A; Gielen J; Merville M P; Bours V
The homeodomain-containing proteins: an update on their interacting partners.
Biochemical pharmacology 1999;58(12):1851-7.
1999: Princen F; Robe P; Lechanteur C; Mesnil M; Rigo J M; Gielen J; Merville M P; Bours V
A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3639-44.
1999: Chariot A; van Lint C; Chapelier M; Gielen J; Merville M P; Bours V
CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein.
Oncogene 1999;18(27):4007-14.
1999: Dejardin E; Deregowski V; Chapelier M; Jacobs N; Gielen J; Merville M P; Bours V
Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells.
Oncogene 1999;18(16):2567-77.
1999: Sautois B; Fraipont V; Baudoux E; Fassotte M F; Hermanne J P; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus J M; Sondag D; Fillet G; Beguin Y
Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
Haematologica 1999;84(4):342-9.
1999: Bonizzi G; Piette J; Schoonbroodt S; Merville M P; Bours V
Role of the protein kinase C lambda/iota isoform in nuclear factor-kappaB activation by interleukin-1beta or tumor necrosis factor-alpha: cell type specificities.
Biochemical pharmacology 1999;57(6):713-20.
1999: Bonizzi G; Piette J; Schoonbroodt S; Greimers R; Havard L; Merville M P; Bours V
Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.
Molecular and cellular biology 1999;19(3):1950-60.
1999: Bentires-Alj M; Hellin A C; Ameyar M; Chouaib S; Merville M P; Bours V
Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs.
Cancer research 1999;59(4):811-5.
1999: Chariot A; Princen F; Gielen J; Merville M P; Franzoso G; Brown K; Siebenlist U; Bours V
IkappaB-alpha enhances transactivation by the HOXB7 homeodomain-containing protein.
The Journal of biological chemistry 1999;274(9):5318-25.
1999: Rezaei Kalantari H; Jerusalem G; Bours V; Fillet G
[Malignant tumors of unknown origin]
Revue médicale de Liège 1999;54(1):39-42.
1999: Matroule J Y; Bonizzi G; Morlière P; Paillous N; Santus R; Bours V; Piette J
Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway.
The Journal of biological chemistry 1999;274(5):2988-3000.
1998: Princen F; Lechanteur C; Lopez M; Rocoux G; Detroz B; Gielen J; Fillet G; Merville M P; Bours V
Repeated cycles of retrovirus-mediated HSVtk gene transfer plus ganciclovir increase survival of rats with peritoneal carcinomatosis.
Gene therapy 1998;5(8):1054-60.
1998: Jerusalem G; Bours V; Fillet G
[Drug clinics. How I treat. II. Therapeutic approaches to metastatic colorectal cancer]
Revue médicale de Liège 1998;53(6):318-21.
1998: Dejardin E; Deregowski V; Greimers R; Cai Z; Chouaib S; Merville M P; Bours V
Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells.
Oncogene 1998;16(25):3299-307.
1998: Jerusalem G; Bours V; Fillet G
[Treatment of colorectal cancer. Pharmaco-economic aspects]
Revue médicale de Liège 1998;53(5):276-8.
1998: de Maisieres P D; Baudoux-Tebache L; Merville M P; Rentier B; Bours V; Piette J
Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kappaB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich region.
The Journal of biological chemistry 1998;273(22):13636-44.
1998: Bours V; Jerusalem G; Fillet G
[How I treat colorectal cancer. I. Prevention and adjuvant treatment]
Revue médicale de Liège 1998;53(4):167-70.
1998: Hellin A C; Calmant P; Gielen J; Bours V; Merville M P
Nuclear factor - kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug.
Oncogene 1998;16(9):1187-95.
1998: Lechanteur C; Princen F; Lo Bue S; Detroz B; Fillet G; Gielen J; Bours V; Merville M P
HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosis.
Advances in experimental medicine and biology 1998;451():115-9.
1997: Bonizzi G; Piette J; Merville M P; Bours V
Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(11):5264-72.
1997: Piette J; Piret B; Bonizzi G; Schoonbroodt S; Merville M P; Legrand-Poels S; Bours V
Multiple redox regulation in NF-kappaB transcription factor activation.
Biological chemistry 1997;378(11):1237-45.
1997: Lechanteur C; Princen F; Lo Bue S; Detroz B; Fillet G; Gielen J; Bours V; Merville M P
HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma-derived peritoneal carcinomatosis.
Gene therapy 1997;4(11):1189-94.
1996: Bonizzi G; Dejardin E; Piret B; Piette J; Merville M P; Bours V
Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates.
European journal of biochemistry / FEBS 1996;242(3):544-9.
1996: Hermanne J P; Tassin F; Bours V; Fillet G
[Retinoids and acute promyelocytic leukemia. A therapeutic revolution]
Revue médicale de Liège 1996;51(3):217-23.
1995: Drew P D; Franzoso G; Becker K G; Bours V; Carlson L M; Siebenlist U; Ozato K
NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(12):1037-45.
1995: Dejardin E; Bonizzi G; Bellahcène A; Castronovo V; Merville M P; Bours V
Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.
Oncogene 1995;11(9):1835-41.
1995: Legrand-Poels S; Bours V; Piret B; Pflaum M; Epe B; Rentier B; Piette J
Transcription factor NF-kappa B is activated by photosensitization generating oxidative DNA damages.
The Journal of biological chemistry 1995;270(12):6925-34.
1995: Antoine N; Bours V; Heinen E; Simar L J; Castronovo V
Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis.
Journal of the National Cancer Institute 1995;87(2):136-9.
1994: Bours V; Azarenko V; Dejardin E; Siebenlist U
Human RelB (I-Rel) functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins.
Oncogene 1994;9(6):1699-702.
1994: Bours V; Dejardin E; Goujon-Letawe F; Merville M P; Castronovo V
The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines.
Biochemical pharmacology 1994;47(1):145-9.
1993: Segars J H; Nagata T; Bours V; Medin J A; Franzoso G; Blanco J C; Drew P D; Becker K G; An J; Tang T
Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers.
Molecular and cellular biology 1993;13(10):6157-69.
1993: Franzoso G; Bours V; Azarenko V; Park S; Tomita-Yamaguchi M; Kanno T; Brown K; Siebenlist U
The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
The EMBO journal 1993;12(10):3893-901.
1993: Bours V; Franzoso G; Azarenko V; Park S; Kanno T; Brown K; Siebenlist U
The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.
Cell 1993;72(5):729-39.
1993: Bressler P; Brown K; Timmer W; Bours V; Siebenlist U; Fauci A S
Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants.
Journal of virology 1993;67(1):288-93.
1992: Franzoso G; Bours V; Park S; Tomita-Yamaguchi M; Kelly K; Siebenlist U
The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
Nature 1992;359(6393):339-42.
1992: Ryseck R P; Bull P; Takamiya M; Bours V; Siebenlist U; Dobrzanski P; Bravo R
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
Molecular and cellular biology 1992;12(2):674-84.
1992: Bours V; Burd P R; Brown K; Villalobos J; Park S; Ryseck R P; Bravo R; Kelly K; Siebenlist U
A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
Molecular and cellular biology 1992;12(2):685-95.
1992: Bours V; Franzoso G; Brown K; Park S; Azarenko V; Tomita-Yamaguchi M; Kelly K; Siebenlist U
Lymphocyte activation and the family of NF-kappa B transcription factor complexes.
Current topics in microbiology and immunology 1992;182():411-20.
1990: Bours V; Villalobos J; Burd P R; Kelly K; Siebenlist U
Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.
Nature 1990;348(6296):76-80.
1990: Beguin Y; Fassotte M F; Hay F; Dokekias A; Andrien F; Bours V; Moutschen M; Runde V; Bury J; Fillet G
[Bone marrow grafts: current status at the University Hospital Center in Liège]
Revue médicale de Liège 1990;45(6):268-79.
1989: Beguin Y; Bours V; Delbrouck J M; Robaye G; Roelandts I; Bury J; Fillet G; Weber G
Relationship of serum selenium levels to tumor activity in acute non-lymphocytic leukemia.
Carcinogenesis 1989;10(11):2089-91.
1987: Fillet G; Bury J; Beguin Y; Duvivier A; Hoyoux C; Bours V
[Hematologic cancers in 1987. Chemotherapy and immunotherapy]
Revue médicale de Liège 1987;42(10):496-502.

Sign-in to see more